Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Extendicare Appoints Dr. Michael R. Guerriere as New President and CEO


Posted on: 11 Sep 18

MARKHAM, Ontario, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:  EXE) is pleased to announce that its Board of Directors has completed its search for a new President and Chief Executive Officer with the appointment of Dr. Michael R. Guerriere effective October 22, 2018. Dr. Guerriere, will be succeeding Tim Lukenda who, as previously announced, is departing the Company.  

Dr. Guerriere, a current member of Extendicare’s Board of Directors, has a diverse background with over 25 years of experience in medicine, healthcare and technology. He is currently the Chief Medical Officer, Vice President and Chief Strategy Officer of TELUS Health, where he oversees the strategy for the company’s eHealth business which serves clinical professionals, hospitals, government agencies, health authorities, pharmacies and consumers across Canada. Prior to joining TELUS Health in 2011, Dr. Guerriere was a founding partner of Courtyard Group, an international healthcare consultancy that TELUS Health acquired. Before starting Courtyard in 2002, he served ten years as an executive in university teaching hospitals, including as Executive Vice President and Chief Operating Officer at the University Health Network. He holds a degree in Medicine and specialty training in Internal Medicine from the University of Toronto, an MBA from the Kellogg School at Northwestern University and an honorary doctorate from Ryerson University.

On behalf of the Board of Directors, Alan Torrie, the Chairman of Extendicare, stated: “We are very pleased with the selection of Dr. Guerriere as the Company’s new President and CEO. We are confident that his background, skills and experience make him ideally suited to lead the Company through its next chapter of growth and continuing success.”

Dr. Guerriere commented, “I’m grateful to the Board for this opportunity. I believe strongly in Extendicare’s growth potential and strategy and look forward to joining the Company’s dedicated team members and caregivers in shaping its future as a leading senior care provider.”

About Extendicare
Extendicare is a leading provider of care and services for seniors throughout Canada. Through our network of 120 operated senior care and living centres (67 owned/53 managed), as well as our home health care operations, we are committed to delivering care throughout the health care continuum to meet the needs of a growing seniors’ population in Canada. Our qualified and highly trained workforce of 23,700 individuals is dedicated to helping people live better through a commitment to quality service and a passion for what we do.

Forward-looking Statements
Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated financial events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, and financial condition. Forward-looking statements can be identified because they generally contain the words “anticipate”, “believe”, “estimate”, “expect”, “intend”, “objective”, “plan”, “project”, “will” or other similar expressions or the negative thereof. Forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available, and Extendicare assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Extendicare to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare’s forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicare’s website at www.extendicare.com.

For further information, contact:
Jillian E. Fountain
Vice President, Investor Relations
Phone: (905) 470-5534; Fax: (905) 470-4003
Email: jfountain@extendicare.com
www.extendicare.com

GlobeNewswire
globenewswire.com

Last updated on: 12/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.